HOUSE BILL No. 5470

 

December 1, 2005, Introduced by Reps. Lemmons, III, Lemmons, Jr., Tobocman, Leland, Kolb, Drolet, Zelenko, Cushingberry and Cheeks and referred to the Committee on Health Policy.

 

      A bill to amend 1978 PA 368, entitled

 

"Public health code,"

 

by amending sections 7212, 7214, 7403, and 7404 (MCL 333.7212,

 

333.7214, 333.7403, and 333.7404), sections 7212, 7403, and 7404

 

as amended by 2002 PA 710 and section 7214 as amended by 1982 PA

 

352, and by adding sections 7337, 7338, 7338a, and 7338b; and to

 

repeal acts and parts of acts.

 

THE PEOPLE OF THE STATE OF MICHIGAN ENACT:

 

 1        Sec. 7212. (1) The following controlled substances are

 

 2  included in schedule 1:

 

 3        (a) Any of the following opiates, including their isomers,

 

 4  esters, the ethers, salts, and salts of isomers, esters, and

 

 5  ethers, unless specifically excepted, when the existence of these


 

 1  isomers, esters, ethers, and salts is possible within the

 

 2  specific chemical designation:

 

 

Acetylmethadol           Difenoxin             Noracymethadol

Allylprodine             Dimenoxadol           Norlevorphanol

Alpha-acetylmethadol     Dimepheptanol         Normethadone

Alphameprodine           Dimethylthiambutene   Norpipanone

Alphamethadol            Dioxaphetyl butyrate  Phenadoxone

Benzethidine             Dipipanone            Phenampromide

Betacetylmethadol        Ethylmethylthiambutene Phenomorphan

10 Betameprodine            Etonitazene           Phenoperidine

11 Betamethadol             Etoxeridine           Piritramide

12 Betaprodine              Furethidine           Proheptazine

13 Clonitazene              Hydroxypethidine      Properidine

14 Dextromoramide           Ketobemidone          Propiram

15 Diampromide              Levomoramide          Racemoramide

16 Diethylthiambutene       Levophenacylmorphan   Trimeperidine

17                          Morpheridine           

18       

 

19        (b) Any of the following opium derivatives, their salts,

 

20  isomers, and salts of isomers, unless specifically excepted, when

 

21  the existence of these salts, isomers, and salts of isomers is

 

22  possible within the specific chemical designation:

 

 

23 Acetorphine              Drotebanol               Morphine-N-Oxide

24 Acetyldihydrocodeine     Etorphine                Myrophine

25 Benzylmorphine           Heroin                   Nicocodeine

26 Codeine methylbromide    Hydromorphinol           Nicomorphine

27 Codeine-N-Oxide          Methyldesorphine         Normorphine

28 Cyprenorphine            Methyldihydromorphine    Pholcodine

29 Desomorphine             Morphine methylbromide   Thebacon

30 Dihydromorphine          Morphine methylsulfonate  

 

 

31        (c) Any material, compound, mixture, or preparation which

 

32  contains any quantity of the following hallucinogenic substances,

 

33  their salts, isomers, and salts of isomers, unless specifically

 

34  excepted, when the existence of these salts, isomers, and salts

 

35  of isomers is possible within the specific chemical designation:

 

 

 


 1  2-Methylamino-1-phenylpropan-1-one

 

 2        Some trade and other names:

 

 3        Methcathinone

 

 4        Cat

 

 5        Ephedrone

 

 6  3, 4-methylenedioxy amphetamine

 

 7        5-methoxy-3, 4-methylenedioxy

 

 8        amphetamine

 

 9  3, 4, 5-trimethoxy amphetamine

 

10        Bufotenine

 

11        Some trade and other names:

 

12        3-(B-dimethylaminoethyl)-5 hydrozyindole

 

13        3-(2-dimethylaminoethyl)-5 indolol

 

14        N,N-dimethylserotonin; 5-hydroxy-N-dimethyltryptamine

 

15        Mappine

 

16  2, 5-Dimethoxyamphetamine

 

17        Some trade or other names:

 

18  2, 5-Dimethoxy-a-methylphenethylamine; 2,5-DMA

 

19  4-Bromo-2, 5-Dimethoxyamphetamine

 

20        Some trade or other names:

 

21        4-bromo-2, 5 dimethoxy-a-methylphenethylamine; 4-bromo

 

22        2,5-DMA

 

23  Diethyltryptamine

 

24        Some trade and other names:

 

25        N,N-Diethyltryptamine; DET

 

26  Dimethyltryptamine

 

27        Some trade or other names:

 


 1        DMT

 

 2  4-methyl-2, 5-dimethoxyamphetamine

 

 3        Some trade and other names:

 

 4        4-methyl-2, 5-dimethoxy-a-methyl-phenethylamine

 

 5        DOM, STP

 

 6  4-methoxyamphetamine

 

 7        Some trade or other names:

 

 8        4-methoxy-a-methylphenethylamine; paramethoxy

 

 9  amphetamine;

 

10        PMA

 

11  Ibogaine

 

12        Some trade and other names:

 

13        7-Ethyl-6,6a,7,8,9,10,12,13

 

14        Octahydro-2-methoxy-6,9-methano-5H-

 

15        pyrido (1, 2:1, 2 azepino 4, 5-b) indole

 

16        tabernanthe iboga

 

17  Lysergic acid diethylamide

 

18  Marihuana, except as otherwise provided in subsection (2)

 

19  Mecloqualone

 

20  Mescaline

 

21  Peyote

 

22  N-ethyl-3 piperidyl benzilate

 

23  N-methyl-3 piperidyl benzilate

 

24  Psilocybin

 

25  Psilocyn

 

26  Thiophene analog of phencyclidine

 

27        Some trade or other names:

 


 1        1-(1-(2-thienyl)cyclohexyl) piperidine)

 

 2        2-thienyl analog of phencyclidine; TPCP

 

 

 

 3        (d)  Except as provided in subsection (2), synthetic  

 

 4  Synthetic equivalents of the substances contained in the plant,

 

 5  or in the resinous extractives of cannabis and synthetic

 

 6  substances, derivatives, and their isomers with similar chemical

 

 7  structure or pharmacological activity, or both, such as the

 

 8  following, are included in schedule 1:

 

 9        (i) ∆1 cis or trans tetrahydrocannabinol, and their optical

 

10  isomers.

 

11        (ii) ∆6 cis or trans tetrahydrocannabinol, and their optical

 

12  isomers.

 

13        (iii) ∆3,4, cis or trans tetrahydrocannabinol, and their

 

14  optical isomers.

 

15        (e) Compounds of structures of substances referred to in

 

16  subdivision (d), regardless of numerical designation of atomic

 

17  positions, are included.

 

18        (f) Gamma-hydroxybutyrate and any isomer, salt, or salt of

 

19  isomer of gamma-hydroxybutyrate.

 

20        Some trade and other names:

 

21        Sodium oxybate

 

22        4-hydroxybutanoic acid monosodium salt

 

23        (g) 3,4-methylenedioxymethamphetamine.

 

24        Some trade and other names:

 

25        Ecstasy

 

26        MDMA

 


 1        (2) Marihuana and the substances described in subsection (1)

 

 2  (d) and (e) in schedule 1 shall be regulated as provided in

 

 3  schedule 2, if they are dispensed in the manner provided in

 

 4  sections 7335 and 7336.

 

 5        (2)  (3)  For purposes of subsection (1), "isomer" includes

 

 6  the optical, position, and geometric isomers.

 

 7        Sec. 7214. The following controlled substances are included

 

 8  in schedule 2:

 

 9        (a) Any of the following substances, except those narcotic

 

10  drugs listed in other schedules, whether produced directly or

 

11  indirectly by extraction from substances of vegetable origin, or

 

12  independently by means of chemical synthesis, or by combination

 

13  of extraction and chemical synthesis:

 

14        (i) Opium and opiate, and any salt, compound, derivative, or

 

15  preparation of opium or opiate excluding nalaxone and its salts,

 

16  and excluding naltrexone and its salts, but including the

 

17  following:

 

 

18 Raw opium                        Etorphine hydrochloride

19 Opium extracts                   Hydrocodone

20 Opium Fluid-extracts             Hydromorphone

21 Powdered opium                   Metopon

22 Granulated opium                 Morphine

23 Tincture of opium                Oxycodone

24 Codeine                          Oxymorphone

25 Ethylmorphine                    Thebaine

 

 

26        (ii) A salt, compound, derivative, or preparation thereof

 

27  which is chemically equivalent to or identical with a substance

 

28  referred to in subdivision (a), except that these substances do

 

29  not include the isoquinoline alkaloids of opium.

 

30        (iii)  Opium poppy, poppy straw, and concentrate of poppy


 

 1  straw, the crude extract of poppy straw in either liquid, solid,

 

 2  or powder form, which contains the phenanthrene alkaloids of the

 

 3  opium poppy.

 

 4        (iv)  Coca leaves and any salt, compound, derivative, or

 

 5  preparation thereof which is chemically equivalent to or

 

 6  identical with any of these substances, except that the

 

 7  substances do not include decocainized coca leaves or extraction

 

 8  of coca leaves which extractions do not contain cocaine or

 

 9  ecgonine. The substances include cocaine, its salts,

 

10  stereoisomers, and salts of stereoisomers when the existence of

 

11  the salts, stereoisomers, and salts of stereoisomers is possible

 

12  within the specific chemical designation.

 

13        (b) Any of the following opiates, including their isomers,

 

14  esters, ethers, salts, and salts of isomers, when the existence

 

15  of these isomers, esters, ethers, and salts is possible within

 

16  the specific chemical designation:

 

 

17 Alphaprodine                     Fentanyl

18 Anileridine                      Isomethadone

19 Bezitramide                      Levomethorphan

20 Dihydrocodeine                   Levorphanol

21 Diphenoxylate                    Metazocine

22                          Methadone

23  Methadone-Intermediate, 4-cyano-2dimethylamino-4, 4-diphenyl

24  butane

25  Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-

26  diphenylpropane-carboxylic acid

 

27                          Pethidine

28  Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine

29  Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

30  Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-

31  carboxylic acid

 

32 Phenazocine                      Racemethorphan

33 Piminodine                       Racemorphan

 


 

 1        (c) Unless listed in another schedule, any material,

 

 2  compound, mixture, or preparation which contains any quantity of

 

 3  the following substances having potential for abuse associated

 

 4  with a stimulant effect on the nervous system:

 

 5        (i) Amphetamine, its salts, optical isomers, and salts of its

 

 6  optical isomers.

 

 7        (ii)  Any substance which contains any quantity of

 

 8  methamphetamine, including its salts, stereoisomers, and salts of

 

 9  stereoisomers.

 

10        (iii)  Phenmetrazine and its salts.

 

11        (iv)  Methylphenidate and its salts.

 

12        (d) Any material, compound, mixture, or preparation,

 

13  including its salts, isomers, and salts of isomers when the

 

14  existence of the salts, isomers, and salts of isomers is possible

 

15  within the specific chemical designation as listed in schedule 2,

 

16  which contains any quantity of the following substances having a

 

17  potential for abuse associated with the depressant effect on the

 

18  central nervous system: methaqualone, amobarbital, pentobarbital,

 

19  or secobarbital; or, any compound, mixture, or preparation

 

20  containing amobarbital, secobarbital, pentobarbital, or any salt

 

21  thereof in combination with itself, with another, or with 1 or

 

22  more other controlled substances.

 

23        (e) Marihuana, but only for use as provided in sections 7335

 

24  and 7336.

 

25        Sec. 7337. As used in this section and sections 7338, 7338a,

 

26  and 7338b:

 

27        (a) "Debilitating medical condition" means 1 or more of the


 

 1  following:

 

 2        (i) Cancer, glaucoma, positive status for human

 

 3  immunodeficiency virus, or acquired immune deficiency syndrome.

 

 4        (ii) A chronic or debilitating disease or medical condition

 

 5  that produces 1 or more of the following: cachexia or wasting

 

 6  syndrome; severe pain; severe nausea; seizures, including those

 

 7  characteristic of epilepsy; or severe and persistent muscle

 

 8  spasms, including those characteristic of multiple sclerosis or

 

 9  Crohn's disease.

 

10        (iii) Any other similar medical condition certified by rules

 

11  promulgated by the department.

 

12        (b) "Medical use" means the acquisition, possession,

 

13  cultivation, use, transfer, or transportation of marihuana or

 

14  paraphernalia relating to the administration of marihuana to

 

15  alleviate the symptoms or effects of a qualifying patient's

 

16  debilitating medical condition.

 

17        (c) "Physician" means an individual licensed as a physician

 

18  under part 170 or an osteopathic physician under part 175.

 

19        (d) "Primary caregiver" means a person who is at least 18

 

20  years old and who has agreed to undertake responsibility for

 

21  managing the well-being of a person with respect to the medical

 

22  use of marihuana.

 

23        (e) "Qualifying patient" means a person who has been

 

24  diagnosed by a physician as having a debilitating medical

 

25  condition.

 

26        (f) "Written certification" means a physician's statement

 

27  under section 7338.


 

 1        Sec. 7338. (1) A physician may issue to a patient who is

 

 2  under his or her care a written statement certifying that, in the

 

 3  physician's professional medical opinion, the patient has a

 

 4  debilitating medical condition and the potential benefits of the

 

 5  medical use of marihuana would likely outweigh the risk to the

 

 6  patient of the medical use of marihuana. A written certification

 

 7  shall not be issued under this subsection unless the physician

 

 8  has made a full assessment of the patient's medical history and

 

 9  medical condition, in the course of a bona fide physician-patient

 

10  relationship.

 

11        (2) A physician shall not be subject to arrest or

 

12  prosecution, penalized in any manner, or denied any right or

 

13  privilege for providing written certification under subsection

 

14  (1).

 

15        (3) Except as provided in section 7338b, a qualifying

 

16  patient who has in his or her possession a written certification

 

17  is not subject to arrest, prosecution, or other penalty for the

 

18  medical use of marihuana, unless the amount of marihuana

 

19  possessed by the qualified patient and his or her primary

 

20  caregivers exceeds the amount reasonably necessary to ensure the

 

21  uninterrupted availability of marihuana for purposes of

 

22  alleviating the symptoms or effects of the qualifying patient's

 

23  debilitating medical condition or its treatment. For purposes of

 

24  this subsection, there is a rebuttable presumption that the

 

25  possession of 3 mature marihuana plants or 4 immature marihuana

 

26  plants, or 3 ounces of dried leaves or flowers of a marihuana

 

27  plant, does not exceed the reasonably necessary amount allowed


 

 1  under this subsection.

 

 2        (4) Subsection (3) does not apply to a minor under the age

 

 3  of 18 years, unless all of the following apply:

 

 4        (a) The minor's physician has explained the potential risks

 

 5  and benefits of the medical use of marihuana to the minor and to

 

 6  the minor's parent or legal guardian.

 

 7        (b) The minor's parent or legal guardian of the minor

 

 8  consents in writing to do all of the following:

 

 9        (i) Allow the minor's medical use of marihuana.

 

10        (ii) Serve as the minor's primary caregiver.

 

11        (iii) Control the acquisition of the marihuana, the dosage,

 

12  and the frequency of the medical use of marihuana by the minor.

 

13        (5) If the acquisition, possession, cultivation,

 

14  transportation, or administration of marihuana by a qualifying

 

15  patient is not practicable, the legal protections established by

 

16  this section for a qualifying patient extend to the qualifying

 

17  patient's primary caregivers, if the primary caregivers' actions

 

18  are necessary for the qualifying patient's medical use of

 

19  marihuana.

 

20        (6) Any property or interest in property that is possessed,

 

21  owned, or used in connection with the medical use of marihuana

 

22  shall not be harmed, neglected, injured, or destroyed while in

 

23  the possession of state or local law enforcement officials,

 

24  except that law enforcement agencies seizing live plants as

 

25  evidence are not responsible for the care and maintenance of

 

26  marihuana plants. Any such property or property interest shall

 

27  not be forfeited under state or local law providing for the


 

 1  forfeiture of property other than as a sentence imposed after

 

 2  conviction of a criminal offense or entry of a plea of guilty to

 

 3  a criminal offense. Marihuana, marihuana paraphernalia, or other

 

 4  property seized from a qualifying patient or primary caregivers

 

 5  in connection with the claimed medical use of marihuana shall be

 

 6  returned immediately upon the determination by a court or

 

 7  prosecuting attorney that the qualifying patient or primary

 

 8  caregivers are entitled to the protections of this section, as

 

 9  may be evidenced by a decision not to prosecute, the dismissal of

 

10  charges, or an acquittal.

 

11        (7) A person shall not be subject to arrest or prosecution

 

12  for constructive possession, conspiracy, or any other offense for

 

13  simply being in the presence or vicinity of the medical use of

 

14  marihuana as permitted under this section.

 

15        Sec. 7338a. A person and a person's primary caregivers may

 

16  assert the medical use of marihuana as a defense to any

 

17  prosecution involving marihuana. This defense shall be presumed

 

18  valid if the evidence shows both of the following:

 

19        (a) The person's medical records indicate, or a physician

 

20  has stated that, in the physician's professional opinion, after

 

21  having completed a full assessment of the person's medical

 

22  history and current medical condition made in the course of a

 

23  bona fide physician-patient relationship, the potential benefits

 

24  of the medical use of marihuana would likely outweigh the health

 

25  risks for the person.

 

26        (b) The person and the person's primary caregivers were

 

27  collectively in possession of a quantity of marihuana that was


 

 1  not more than was reasonably necessary to ensure the

 

 2  uninterrupted availability of marihuana for the purpose of

 

 3  alleviating the symptoms or effects of the person's medical

 

 4  condition.

 

 5        Sec. 7338b. (1) The authorization for the medical use of

 

 6  marihuana under sections 7337 to 7337a does not apply to any of

 

 7  the following:

 

 8        (a) The medical use of marihuana that endangers the health

 

 9  or well-being of another person, such as driving or operating

 

10  heavy machinery while under the influence of marihuana.

 

11        (b) The smoking of marihuana in any of the following places:

 

12        (i) A school bus, public bus, or other public vehicle.

 

13        (ii) The workplace of one's employment.

 

14        (iii) Any school grounds.

 

15        (iv) Any correctional facility.

 

16        (v) Any public park, public beach, public recreation center,

 

17  or youth center.

 

18        (c) The use of marihuana by a qualifying patient, primary

 

19  caregiver, or any other person for purposes other than medical

 

20  use permitted by sections 7337 to 7337a.

 

21        (2) A person shall not fraudulently represent to a law

 

22  enforcement official any fact or circumstance relating to the

 

23  medical use of marihuana to avoid arrest or prosecution. A person

 

24  who violates this subsection is guilty of a misdemeanor

 

25  punishable by imprisonment for not more than 30 days or a fine of

 

26  not more than $500.00, or both.

 

27        Sec. 7403. (1) A person shall not knowingly or intentionally


 

 1  possess a controlled substance, a controlled substance analogue,

 

 2  or a prescription form unless the controlled substance,

 

 3  controlled substance analogue, or prescription form was obtained

 

 4  directly from, or pursuant to, a valid prescription or order of a

 

 5  practitioner while acting in the course of the practitioner's

 

 6  professional practice, or except as otherwise authorized by this

 

 7  article.

 

 8        (2) A person who violates this section as to:

 

 9        (a) A controlled substance classified in schedule 1 or 2

 

10  that is a narcotic drug or a drug described in section

 

11  7214(a)(iv), and:

 

12        (i) Which is in an amount of 1,000 grams or more of any

 

13  mixture containing that substance is guilty of a felony

 

14  punishable by imprisonment for life or any term of years or a

 

15  fine of not more than $1,000,000.00, or both.

 

16        (ii) Which is in an amount of 450 grams or more, but less

 

17  than 1,000 grams, of any mixture containing that substance is

 

18  guilty of a felony punishable by imprisonment for not more than

 

19  30 years or a fine of not more than $500,000.00, or both.

 

20        (iii) Which is in an amount of 50 grams or more, but less than

 

21  450 grams, of any mixture containing that substance is guilty of

 

22  a felony punishable by imprisonment for not more than 20 years or

 

23  a fine of not more than $250,000.00, or both.

 

24        (iv) Which is in an amount of 25 grams or more, but less than

 

25  50 grams of any mixture containing that substance is guilty of a

 

26  felony punishable by imprisonment for not more than 4 years or a

 

27  fine of not more than $25,000.00, or both.


 

 1        (v) Which is in an amount less than 25 grams of any mixture

 

 2  containing that substance is guilty of a felony punishable by

 

 3  imprisonment for not more than 4 years or a fine of not more than

 

 4  $25,000.00, or both.

 

 5        (b) Either of the following:

 

 6        (i) A substance described in section 7212(1)(g) or 7214(c)(ii)

 

 7  is guilty of a felony punishable by imprisonment for not more

 

 8  than 10 years or a fine of not more than $15,000.00, or both.

 

 9        (ii) A controlled substance classified in schedule 1, 2, 3,

 

10  or 4, except a controlled substance for which a penalty is

 

11  prescribed in subdivision (a), (b)(i), (c), or (d), or a

 

12  controlled substance analogue is guilty of a felony punishable by

 

13  imprisonment for not more than 2 years or a fine of not more than

 

14  $2,000.00, or both.

 

15        (c) Lysergic acid diethylamide, peyote, mescaline,

 

16  dimethyltryptamine, psilocyn, psilocybin, or a controlled

 

17  substance classified in schedule 5 is guilty of a misdemeanor

 

18  punishable by imprisonment for not more than 1 year or a fine of

 

19  not more than $2,000.00, or both.

 

20        (d) Marihuana is guilty of a misdemeanor punishable by

 

21  imprisonment for not more than 1 year or a fine of not more than

 

22  $2,000.00, or both.

 

23        (e) A prescription form is guilty of a misdemeanor

 

24  punishable by imprisonment for not more than 1 year or a fine of

 

25  not more than $1,000.00, or both.

 

26        (3) If an individual was sentenced to lifetime probation

 

27  under subsection (2)(a)(iv) before  the effective date of the


 

 1  amendatory act that added this subsection  April 1, 2003 and the

 

 2  individual has served 5 or more years of that probationary

 

 3  period, the probation officer for that individual may recommend

 

 4  to the court that the court discharge the individual from

 

 5  probation. If an individual's probation officer does not

 

 6  recommend discharge as provided in this subsection, with notice

 

 7  to the prosecutor, the individual may petition the court seeking

 

 8  resentencing under the court rules. The court may discharge an

 

 9  individual from probation as provided in this subsection. An

 

10  individual may file more than 1 motion seeking resentencing under

 

11  this subsection.

 

12        (4) This section does not apply to the medical use of

 

13  marihuana allowed under sections 7337 to 7338b.

 

14        Sec. 7404. (1) A person shall not use a controlled substance

 

15  or controlled substance analogue unless the substance was

 

16  obtained directly from, or pursuant to, a valid prescription or

 

17  order of a practitioner while acting in the course of the

 

18  practitioner's professional practice, or except as otherwise

 

19  authorized by this article.

 

20        (2) A person who violates this section as to:

 

21        (a) A controlled substance classified in schedule 1 or 2 as

 

22  a narcotic drug or a drug described in section 7212(1)(g) or

 

23  7214(a)(iv) or (c)(ii) is guilty of a misdemeanor punishable by

 

24  imprisonment for not more than 1 year or a fine of not more than

 

25  $2,000.00, or both.

 

26        (b) A controlled substance classified in schedule 1, 2, 3,

 

27  or 4, except a controlled substance for which a penalty is


 

 1  prescribed in subdivision (a), (c), or (d), or a controlled

 

 2  substance analogue, is guilty of a misdemeanor punishable by

 

 3  imprisonment for not more than 1 year or a fine of not more than

 

 4  $1,000.00, or both.

 

 5        (c) Lysergic acid diethylamide, peyote, mescaline,

 

 6  dimethyltryptamine, psilocyn, psilocybin, or a controlled

 

 7  substance classified in schedule 5, is guilty of a misdemeanor

 

 8  punishable by imprisonment for not more than 6 months or a fine

 

 9  of not more than $500.00, or both.

 

10        (d) Marihuana, is guilty of a misdemeanor punishable by

 

11  imprisonment for not more than 90 days or a fine of not more than

 

12  $100.00, or both.

 

13        (3) This section does not apply to the medical use of

 

14  marihuana allowed under sections 7337 to 7338b.

 

15        Enacting section 1. Sections 7335 and 7336 of the public

 

16  health code, 1978 PA 368, MCL 333.7335 and 333.7336, are

 

17  repealed.